B
Beyond Air, Inc. (XAIR)
NCM – Real vaqt narxi. Valyuta: USD
5.60
-0.24 (-4.11%)
Bozor ochiq: Aug 12, 2026, 12:54 PM EDT
5.85
+0.01 (0.16%)
Oldingi bozordan keyin: Aug 11, 2026, 7:52 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
5.60
-0.24 (-4.11%)
Bozor ochiq: Aug 12, 2026, 12:54 PM EDT
5.85
+0.01 (0.16%)
Oldingi bozordan keyin: Aug 11, 2026, 7:52 PM EDT
Beyond Air, Inc. tijorat bosqichidagi tibbiy va biofarmatsevtika kompaniyasi sifatida faoliyat yuritadi. U Beyond Air, Beyond Cancer va NeuroNos bo'limlari orqali ishlaydi. Kompaniya yangi tug'ilgan chaqaloqlarda o'tkir o'pka gipertenziyasini davolash uchun Lungfit PH-ni taklif etadi. Shuningdek, u shifoxonada yotgan bemorlarda virusli o'pka infektsiyalari, jumladan, virusli jamoada orttirilgan pnevmoniya, shu jumladan COVID-19 va bronxiolitni davolash uchun LungFit PRO; va tuberkulyoz bo'lmagan mikobakteriyalarni (NTM) davolash uchun LungFit GO-ni ishlab chiqmoqda. Bundan tashqari, kompaniya qattiq o'smalarni davolash uchun 1-faza klinik sinovlarida bo'lgan ultra-yuqori konsentratsiyali NO (UNO) va nevrologik kasalliklarni davolash uchun selektiv neyronal nitrik oksidi sintez (nNOS) inhibitörünü ishlab chiqmoqda. Kompaniya Yissum Research Development Company of the Hebrew University of Jerusalem, LTD bilan hamkorlik qilib, avtizm spektrining buzilishi va boshqa nevrologik kasalliklarni davolash uchun neyronal nitrik oksidi sintez inhibitörlerinin tijoriy huquqlarini olish uchun hamkorlik qiladi. Kompaniya ilgari AIT Therapeutics, Inc. nomi bilan tanilgan va 2019-yil iyun oyida nomini Beyond Air, Inc.ga o'zgartirgan. Beyond Air, Inc. 2011-yilda tashkil etilgan va Nyu-York shtatining Garden City shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Andrew R. Colin M.D. | Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board |
| Dr. John Jett Ph.D. | Head of Research & Clinical Development |
| Mr. Adam T. Newman | Corporate Secretary |
| Mr. Amir Avniel | Chief Executive Officer of NeuroNOS |
| Mr. Daniel J. Moorhead CPA | Chief Financial Officer |
| Mr. Denton Drewell | Principal Accounting Officer & Controller |
| Mr. Michael A. Gaul | Chief Operating Officer |
| Mr. Robert Scott Goodman | CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-06 | 8-K | form8-k.htm |
| 2026-07-31 | 8-K | form8-k.htm |
| 2026-07-09 | 8-K | form8-k.htm |
| 2026-06-26 | 8-K | form8-k.htm |
| 2026-06-26 | 10-K | form10-k.htm |
| 2026-06-22 | 8-K | form8-k.htm |
| 2026-06-01 | 8-K | form8-k.htm |
| 2026-05-05 | DEF 14A | formdef14a.htm |
| 2026-04-24 | PRE 14A | formpre14a.htm |
| 2026-04-15 | 8-K | form8-k.htm |